Top Markets
Coin of the day
Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc.

SPPI
Rangering i aksjer #21095
Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily... Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induced neutropenia. Also under development is Poziotinib, a distinct irreversible tyrosine kinase inhibitor intended for non-small cell lung cancer tumors exhibiting various mutations. Furthermore, Anti-CD20-IFNa, an antibody-interferon fusion molecule targeting CD20, is progressing through Phase I development for patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. The company maintains key collaborative agreements, such as co-development, commercialization, and in-licensing arrangements with Hanmi Pharmaceutical Co. Ltd., a patent and technology license with The University of Texas M.D. Anderson Cancer Center, and an in-license pact with ImmunGene, Inc. Founded in 1987, and initially known as NeoTherapeutics, Inc. before its name change in December 2002, Spectrum Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Aksjekurs
$1.03
Sist synkronisert: 2023-07-31
Markedsverdi
$115.13M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Spectrum Pharmaceuticals, Inc. (SPPI)

Kategori

Aksjeprishistorikk for Spectrum Pharmaceuticals, Inc. (SPPI)
Høyeste sluttskurs: $0.98 den 2023-07-01

Laveste sluttskurs: $146.88 den 1996-09-01
Aksjeprishistorikk for Spectrum Pharmaceuticals, Inc. fra 1996 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 142.39%
2022 -72.40%
2021 -66.76%
2020 -45.64%
2019 -24.79%
2018 -42.30%
2017 324.76%
2016 -24.40%
2015 -18.21%
2014 -20.89%
2013 -20.68%
2012 -21.84%
2011 142.92%
2010 27.82%
2009 208.32%
2008 -48.89%
2007 -47.10%
2006 36.47%
2005 -30.49%
2004 -16.52%
2003 256.95%
2002 -97.89%
2001 -26.14%
2000 -57.96%
1999 39.74%
1998 -8.28%
1997 119.65%
1996 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH